| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 5480 |
| 1 | EVOLOCUMAB | 3254 |
| 2 | ETANERCEPT | 2708 |
| 3 | ALBUTEROL SULFATE | 1960 |
| 4 | DENOSUMAB | 1906 |
| 5 | ERENUMAB-AOOE | 1874 |
| 6 | ABATACEPT | 1624 |
| 7 | DUPILUMAB | 1461 |
| 8 | INSULIN LISPRO | 1268 |
| 9 | USTEKINUMAB | 918 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RITUXIMAB-ARRX | 65 | 0.5702 |
| 1 | ADALIMUMAB-ATTO | 53 | 0.2314 |
| 2 | DILUENT | 189 | 0.1835 |
| 3 | CLASCOTERONE | 109 | 0.1778 |
| 4 | INFLIXIMAB-AXXQ | 55 | 0.1647 |
| 5 | TRASTUZUMAB-ANNS | 146 | 0.1535 |
| 6 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 291 | 0.1321 |
| 7 | INSULIN GLARGINE AND LIXISENATIDE | 263 | 0.1151 |
| 8 | TRIENTINE HYDROCHLORIDE | 12 | 0.0789 |
| 9 | EPOETIN ALFA | 720 | 0.0670 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 6771 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 3574 |
| 2 | PCSK9 Inhibitor [EPC] | 3526 |
| 3 | RANK Ligand Inhibitor [EPC] | 1906 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 1624 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1461 |
| 6 | Interleukin-23 Antagonist [EPC] | 1422 |
| 7 | GLP-1 Receptor Agonist [EPC] | 1066 |
| 8 | Corticosteroid [EPC] | 951 |
| 9 | Interleukin-12 Antagonist [EPC] | 918 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Skin Test Antigen [EPC] | 291 | 0.1317 |
| 1 | Thyroid Stimulating Hormone [EPC] | 22 | 0.0279 |
| 2 | PCSK9 Inhibitor [EPC] | 3526 | 0.0275 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 81 | 0.0243 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 438 | 0.0223 |
| 5 | Interferon alfa-2b [EPC] | 12 | 0.0213 |
| 6 | l-Triiodothyronine [EPC] | 1 | 0.0200 |
| 7 | Recombinant Human Nerve Growth Factor [EPC] | 86 | 0.0200 |
| 8 | Melanin Synthesis Inhibitor [EPC] | 17 | 0.0185 |
| 9 | Insulin Analog [EPC] | 6771 | 0.0175 |